The use of convection-enhanced delivery with liposomal toxins in neurooncology

Citations of this article
Mendeley users who have this article in their library.


Liposomes have long been effective delivery vehicles for transport of toxins to peripheral cancers. The combination of convection-enhanced delivery (CED) with liposomal toxins was originally proposed to circumvent the limited delivery of intravascular liposomes to the central nervous system (CNS) due to the blood-brain-barrier (BBB). CED offers markedly improved distribution of infused therapeutics within the CNS compared to direct injection or via drug eluting polymers, both of which depend on diffusion for parenchymal distribution. This review examines the basis for improved delivery of liposomal toxins via CED within the CNS, and discusses preclinical and clinical experience with these therapeutic techniques. How CED and liposomal technologies may influence future neurooncologic treatments are also considered. © 2011 by the authors; licensee MDPI, Basel, Switzerland.




Fiandaca, M. S., Berger, M. S., & Bankiewicz, K. S. (2011, April). The use of convection-enhanced delivery with liposomal toxins in neurooncology. Toxins.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free